Skip to content

Today's Technology For Tomorrow's Kidney Care

Intestinal Dialysis™     A Break Through technology

In transition from Kidney health supplement to a live biotherapeutic product (LBP) development under CBER/USFD approved Investigational New Drug(IND) for multisite RCT, CKD patients (N=630).For more details refer to Clinical Trials. 

Intestinal Dialysis™ (a.k.a Enteric Dialysis®) – Modulating the Gut Microbiome with Probiotics and Prebiotics (Gut-Kidney Connection)

Kibow's - Intestinal Dialysis™Award winning and patented technology

2020 Business of the Year

Delaware County Chamber of Commerce

Bio - Biotechnology Innovation Organization

2005 - Innovation Corridor Abstract Winner, Boston, MA

2018 - Invited Company for Presentation, Boston, MA

Kibow Buzz of Bio Winner (Kidney Health)

2014 - A “Buzz of Bio" Winner

Pipelines of Promise category, International Bio conference, San Diego, CA

The first dietary supplement Company nominated to participate in the "Buzz of Bio".

2019 - Dun & Bradstreet Award

In recognition of unwavering commitment to business growth

Supported by Visionary & Distinguished Nephrologists and Scientists

“WILL THE BOWEL BE THE KIDNEY OF THE FUTURE”

SYMPOSIUM AT THE INTERNATIONAL SOCIETY OF ARTIFICIAL INTERNAL ORGANS IN EDINBURGH, SCOTLAND. Aug 04, 1999

Subscribe Newsletter &Get Company News